These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 22457820

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Confirmation of the HOXB13 G84E germline mutation in familial prostate cancer.
    Breyer JP, Avritt TG, McReynolds KM, Dupont WD, Smith JR.
    Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1348-53. PubMed ID: 22714738
    [Abstract] [Full Text] [Related]

  • 3. Truncating mutations of TP53AIP1 gene predispose to cutaneous melanoma.
    Benfodda M, Gazal S, Descamps V, Basset-Seguin N, Deschamps L, Thomas L, Lebbe C, Saiag P, Zanetti R, Sacchetto L, Chiorino G, Scatolini M, Grandchamp B, Bensussan A, Soufir N.
    Genes Chromosomes Cancer; 2018 Jun; 57(6):294-303. PubMed ID: 29359367
    [Abstract] [Full Text] [Related]

  • 4. Apoptosis gene polymorphisms and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy.
    Meyer A, Coinac I, Bogdanova N, Dubrowinskaja N, Turmanov N, Haubold S, Schürmann P, Imkamp F, von Klot C, Merseburger AS, Machtens S, Bremer M, Hillemanns P, Kuczyk MA, Karstens JH, Serth J, Dörk T.
    Urol Oncol; 2013 Jan; 31(1):74-81. PubMed ID: 21396839
    [Abstract] [Full Text] [Related]

  • 5. A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk.
    Karlsson R, Aly M, Clements M, Zheng L, Adolfsson J, Xu J, Grönberg H, Wiklund F.
    Eur Urol; 2014 Jan; 65(1):169-76. PubMed ID: 22841674
    [Abstract] [Full Text] [Related]

  • 6. Germline BRCA mutations denote a clinicopathologic subset of prostate cancer.
    Gallagher DJ, Gaudet MM, Pal P, Kirchhoff T, Balistreri L, Vora K, Bhatia J, Stadler Z, Fine SW, Reuter V, Zelefsky M, Morris MJ, Scher HI, Klein RJ, Norton L, Eastham JA, Scardino PT, Robson ME, Offit K.
    Clin Cancer Res; 2010 Apr 01; 16(7):2115-21. PubMed ID: 20215531
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Germline genetic variants in men with prostate cancer and one or more additional cancers.
    Pilié PG, Johnson AM, Hanson KL, Dayno ME, Kapron AL, Stoffel EM, Cooney KA.
    Cancer; 2017 Oct 15; 123(20):3925-3932. PubMed ID: 28657667
    [Abstract] [Full Text] [Related]

  • 13. Truncating variants in p53AIP1 disrupting DNA damage-induced apoptosis are associated with prostate cancer risk.
    Wang X, Wang F, Taniguchi K, Seelan RS, Wang L, Zarfas KE, McDonnell SK, Qian C, Pan K, Lu Y, Shridhar V, Couch FJ, Tindall DJ, Beebe-Dimmer JL, Cooney KA, Isaacs WB, Jacobsen SJ, Schaid DJ, Thibodeau SN, Liu W.
    Cancer Res; 2006 Nov 01; 66(21):10302-7. PubMed ID: 17079449
    [Abstract] [Full Text] [Related]

  • 14. A novel founder CHEK2 mutation is associated with increased prostate cancer risk.
    Cybulski C, Huzarski T, Górski B, Masojć B, Mierzejewski M, Debniak T, Gliniewicz B, Matyjasik J, Złowocka E, Kurzawski G, Sikorski A, Posmyk M, Szwiec M, Czajka R, Narod SA, Lubiński J.
    Cancer Res; 2004 Apr 15; 64(8):2677-9. PubMed ID: 15087378
    [Abstract] [Full Text] [Related]

  • 15. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
    Jonsson BA, Bergh A, Stattin P, Emmanuelsson M, Grönberg H.
    Int J Cancer; 2002 Apr 20; 98(6):838-43. PubMed ID: 11948460
    [Abstract] [Full Text] [Related]

  • 16. Germline mutations in the BRCA2 gene and susceptibility to hereditary prostate cancer.
    Agalliu I, Kwon EM, Zadory D, McIntosh L, Thompson J, Stanford JL, Ostrander EA.
    Clin Cancer Res; 2007 Feb 01; 13(3):839-43. PubMed ID: 17289875
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients.
    Lee DS, Yoon SY, Looi LM, Kang P, Kang IN, Sivanandan K, Ariffin H, Thong MK, Chin KF, Mohd Taib NA, Yip CH, Teo SH.
    Breast Cancer Res; 2012 Apr 16; 14(2):R66. PubMed ID: 22507745
    [Abstract] [Full Text] [Related]

  • 20. Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer.
    Isaacsson Velho P, Silberstein JL, Markowski MC, Luo J, Lotan TL, Isaacs WB, Antonarakis ES.
    Prostate; 2018 Apr 16; 78(5):401-407. PubMed ID: 29368341
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.